Ceribell (CBLL) Amortizatization of Intangibles (2023 - 2026)
Ceribell (CBLL) posted Amortizatization of Intangibles of $555000.0 for Q1 2026, down 67.41% on a QoQ basis from $1.7 million in Q4 2025, and up 3164.71% year-over-year from $17000.0 in Q1 2025.
Ceribell (CBLL) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Ceribell's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $555000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 3164.71% year-over-year to $555000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 722.26% YoY) and the FY2025 annual result came in at $2.0 million, up 426.44% from the prior year.
- Amortizatization of Intangibles was $555000.0 for Q1 2026 at Ceribell, down from $1.7 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.7 million in Q4 2025 and bottomed at -$179000.0 in Q3 2025.
- A 4-year average of $303800.0 and a median of $92000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles plunged 296.7% — and 2026, when it jumped 3164.71%.
- Ceribell's Amortizatization of Intangibles stood at $90000.0 in 2023, then grew by 3.33% to $93000.0 in 2024, then surged by 1731.18% to $1.7 million in 2025, then sank by 67.41% to $555000.0 in 2026.
- Business Quant data shows CBLL's Amortizatization of Intangibles at $555000.0 in Q1 2026, $1.7 million in Q4 2025, and -$179000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Ceribell | 677.56 Mn | 536.38 Mn | 23.12 Mn | 555,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 555,000.00 |
| Mar 31, 2026 | 555,000.00 |
| Dec 31, 2025 | 1.70 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | -179,000.00 |
| Sep 30, 2025 | -179,000.00 |
| Jun 30, 2025 | 470,000.00 |
| Jun 30, 2025 | 470,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 109,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Dec 31, 2023 | 90,000.00 |